FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

LAURUSLABS

322.3
+2.45 (0.77%)
Updated 01:17 04/12 IST

LAURUSLABS Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for LAURUSLABS
Disclaimer
0% Bullish
0% Bearish

LAURUSLABS Buy or Sell - Brokerage Reports

No. of reports in last year
2
No. of analysts
2
Average Consensus Forecast
367.5
Consensus Potential
11.79%
See LAURUSLABS Share Price Targets >>

LAURUSLABS Ratings

Long term LAURUSLABS rating by FrontPage users
5/5 (3 Ratings)
Find answers to all your questions on live LAURUSLABS message board: Is LAURUSLABS buy or sell? Should I buy LAURUSLABS shares? Why are LAURUSLABS shares falling? Should I invest in LAURUSLABS stock?

  1. Home
  2. LAURUSLABS Forum

LAURUSLABS Share Price Discussion

N
Reputation: 8,253 • Dec 2 4:16 AM
Up 341% YTD, this midcap pharma stock has just got more attractive
Kotak Securities said the acquisition of Richmore would be value accretive for the company, though the incoming revenue is small to impact the near-term earnings profile.
The Economic Times
Like
Reply

SELL SILVER MAR @ 62450-62550

Like
Reply
P
Reputation: 27,025 • Dec 2 4:15 AM

Type
Sell
Instrument
ZINC 31DEC20 FUT
Entry Price
₹216.2
Price@Trade
₹216.3
Target Price
₹215
Stop Price
₹217
Valid Till
Dec 2, 2020 11:20 AM
Margin
₹123,518.75 approx for 5000 Qty
Status
Waiting for entry
Like
Reply
2
Reputation: -158 • Dec 2 4:15 AM

Type
Buy
Instrument
PHILIPCARB
Entry Price
₹176.05
Price@Trade
₹176.05
Target Price
₹200
Stop Price
₹155
Valid Till
Jan 1, 2021 3:20 AM
Margin
₹88,025 approx for 500 Qty
Status
Active
Like
Reply
P
Reputation: 283,404 • Dec 2 4:15 AM

Type
Buy
Instrument
BANKNIFTY 03DEC20 29800 PE
Entry Price
₹350
Price@Trade
₹365
Target Price
₹450
Stop Price
₹250
Valid Till
Dec 2, 2020 3:20 AM
Margin
₹1,750,000 approx for 5000 Qty
Status
Waiting for entry
Like
Reply
S
Reputation: 1,454 • Dec 2 4:14 AM

Type
Buy
Instrument
BAJAJ-AUTO DEC20 FUT
Entry Price
₹3,308.1
Price@Trade
₹3,308.1
Target Price
₹3,345
Stop Price
₹3,279
Valid Till
Dec 2, 2020 3:20 AM
Margin
₹177,123.88 approx for 250 Qty
Status
Active
Like
Reply
F
Reputation: 1,597 • Dec 2 4:14 AM

Type
Buy
Instrument
BPCL DEC20 FUT
Entry Price
₹389.2
Price@Trade
₹389.2
Target Price
₹396
Stop Price
₹385
Valid Till
Dec 3, 2020 3:20 AM
Margin
₹302,079.6 approx for 1800 Qty
Status
Active
Like
Reply
K
Reputation: -789 • Dec 2 4:13 AM

Type
Buy
Instrument
AXISBANK DEC20 570 PE
Entry Price
₹13
Price@Trade
₹12.9
Target Price
₹30
Stop Price
₹11
Valid Till
Dec 31, 2020 3:20 AM
Margin
₹15,600 approx for 1200 Qty
Status
Waiting for entry
Like
Reply
P
Reputation: 27,025 • Dec 2 4:13 AM

Type
Sell
Instrument
ZINC 31DEC20 FUT
Entry Price
₹216.25
Price@Trade
₹216.25
Target Price
₹215
Stop Price
₹217
Valid Till
Dec 2, 2020 11:20 AM
Margin
₹123,515.63 approx for 5000 Qty
Status
Active
Like
Reply
R
Reputation: 21,333 • Dec 2 4:13 AM

Type
Buy
Instrument
BANKNIFTY 31DEC20 FUT
Entry Price
₹29,718.35
Price@Trade
₹29,718.35
Target Price
₹29,920
Stop Price
₹29,648
Valid Till
Dec 31, 2020 3:20 AM
Margin
₹639,601.7 approx for 100 Qty
Status
Active
Like
Reply
N
Reputation: 1,484 • Dec 2 4:13 AM

Type
Sell
Instrument
GRAPHITE
Entry Price
₹257.9
Price@Trade
₹256.35
Target Price
₹255
Stop Price
₹260.5
Valid Till
Dec 2, 2020 3:20 AM
Margin
₹773,700 approx for 3000 Qty
Status
Exited before entry
Like
Reply (1)
See all replies
Nikhil @nikhil-ryOaIDo9v
Dec 2 4:14 AM

Update
Exited before entry
Price @ Update
₹255.8
T
Reputation: 85,373 • Dec 2 4:13 AM

Type
Buy
Instrument
BANKNIFTY 03DEC20 29700 CE
Entry Price
₹302
Price@Trade
₹281.25
Target Price
₹350
Stop Price
₹259
Valid Till
Dec 2, 2020 3:20 AM
Margin
₹151,000 approx for 500 Qty
Status
Waiting for entry
Like
Reply
S
Reputation: 2,454 • Dec 2 4:13 AM

02-12-20
RELIANCE BUY DEC FUT (Intraday)
only above @ 1954
Like
Reply
P
Reputation: 27,025 • Dec 2 4:13 AM

Type
Sell
Instrument
ZINC 31DEC20 FUT
Entry Price
₹216.2
Price@Trade
₹216.2
Target Price
₹215
Stop Price
₹217
Valid Till
Dec 2, 2020 11:20 AM
Margin
₹617,562.5 approx for 25000 Qty
Status
Active
Like
Reply
T
Reputation: 10,069 • Dec 2 4:13 AM

Type
Sell
Instrument
IGL DEC20 FUT
Entry Price
₹478
Price@Trade
₹476.85
Target Price
₹471
Stop Price
₹485
Valid Till
Dec 2, 2020 3:20 AM
Margin
₹160,558.41 approx for 1375 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
VTL
Entry Price
₹873
Price@Trade
₹871.95
Target Price
₹1,100
Stop Price
₹802
Valid Till
Jan 1, 2021 3:20 AM
Margin
₹87,300 approx for 100 Qty
Status
Waiting for entry
Like
Reply
R
Reputation: 21,333 • Dec 2 4:12 AM

Type
Buy
Instrument
BANKNIFTY 03DEC20 29900 CE
Entry Price
₹195
Price@Trade
₹193.55
Target Price
₹280
Stop Price
₹110
Valid Till
Dec 3, 2020 3:20 AM
Margin
₹19,500 approx for 100 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
ISEC
Entry Price
₹453
Price@Trade
₹453
Target Price
₹479
Stop Price
₹437
Valid Till
Jan 1, 2021 3:20 AM
Margin
₹22,650 approx for 50 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
LICHSGFIN
Entry Price
₹342
Price@Trade
₹343.3
Target Price
₹347
Stop Price
₹338
Valid Till
Dec 2, 2020 3:20 AM
Margin
₹171,000 approx for 500 Qty
Status
Waiting for entry
Like
Reply
S
Reputation: 1,454 • Dec 2 4:12 AM

Type
Buy
Instrument
ASIANPAINT DEC20 FUT
Entry Price
₹2,299.95
Price@Trade
₹2,299.95
Target Price
₹2,326
Stop Price
₹2,290
Valid Till
Dec 2, 2020 3:20 AM
Margin
₹138,635.48 approx for 300 Qty
Status
Active
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • LAURUSLABS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization4,254.94
    Enterprise Value5,170.37
    Price to Earnings30.81
    Price to Book Value2.68
    Return on Capital Employed0.13
    Return on Equity0.11
    Face Value10
    Dividend YieldNA
  • LAURUSLABS - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    26-Nov-20Motilal OswalBuy410
    29-Sep-20ICICIdirect.comHold325
    5-Aug-19HDFC SecuritiesBuy471
    17-Jul-19HDFC SecuritiesBuy515
    1-Jul-19Kotak SecuritiesBuy430
    LAURUSLABS Brokerage Price Target
  • LAURUSLABS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Dec 3322.5322.8318319.85
    Dec 2324.4325317321.15
    Dec 1320.05326.6311322.9
    Nov 27292.65321291316.85
    Nov 26295298.8289.3292.35
  • LAURUSLABS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹287.79
    30 Day Moving Average₹299.4
    50 Day Moving Average₹435.19
    100 Day Moving Average₹717.7
    200 Day Moving Average₹582.52
  • LAURUSLABS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue2,039.291,891.920.08
    Operating Profit408.75415.62-0.02
    Profit Before Tax240.91247.63-0.03
    Net Income173.14202.57-0.15
  • LAURUSLABS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,5901,513.30.05
    Total Liabilities1,7271,612.410.07
    Total Assets3,3183,125.710.06
  • LAURUSLABS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity368.6320.060.15
    Cash from Investing Activity-417.48-280.950.49
    Cash from Financing Activity48.99-47.31-2.04
    Net Cash Flow0.12-8.21-1.01
  • LAURUSLABS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.060.08
    Return on Equity0.110.15
    Return on Capital Employed0.130.16
  • LAURUSLABS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.54
    3 Year CAGR Growth in Operating Profit0.99
    3 Year CAGR Growth in EBIDTA0.83
    3 Year CAGR Growth in Net Income1.36
    3 Yr CAGR Growth - Diluted EPS0.82
  • LAURUSLABS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.82
    5 Year CAGR Growth in Operating Profit1.82
    5 Year CAGR Growth in EBIDTA1.92
    5 Year CAGR Growth in Net Income0.96
    3 Yr CAGR Growth - Diluted EPS0.44
  • LAURUSLABS - Recent News

    keyboard_arrow_down
    NewsBot
    Dec 2 4:16 AM
    Up 341% YTD, this midcap pharma stock has just got more attractive
    The Economic Times
    NewsBot
    Nov 27 4:56 AM
    Buy Laurus Labs, target price Rs 410: Motilal Oswal
    The Economic Times
    NewsBot
    Nov 26 2:23 AM
    Laurus Labs says Richcore buy will help it become a leading biotech contract manufacturer
    Moneycontrol
    NewsBot
    Nov 26 6:01 AM
    Buy Laurus Labs, target price Rs 400: Motilal Oswal
    The Economic Times
    NewsBot
    Nov 26 5:01 AM
    Laurus Labs jumps 4% on acquisition of Richcore Lifesciences
    The Economic Times
    NewsBot
    Nov 5 4:26 AM
    Looking for stock ideas? Don’t miss the 35 firms that grew Q2 profit up to 1,200%
    The Economic Times
    NewsBot
    Nov 4 3:13 AM
    Buy Laurus Labs; target of Rs 390: ICICI Direct
    Moneycontrol
    NewsBot
    Nov 3 10:48 AM
    Accumulate Laurus Labs; target of Rs 400: Dolat Capital Market
    Moneycontrol
    NewsBot
    Nov 2 8:48 AM
    Buy Laurus Labs; target of Rs 385: Sharekhan
    Moneycontrol
    NewsBot
    Nov 2 6:28 AM
    Buy Laurus Labs; target of Rs 400: Motilal Oswal
    Moneycontrol
  • LAURUSLABS - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020